A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis.

Frohman, Elliot M; Cutter, Gary; Remington, Gina; Gao, Hongjiang; Rossman, Howard; Weinstock-Guttman, Bianca; Durfee, Jacqueline E; Conger, Amy; Carl, Ellen; Treadaway, Katherine; Lindzen, Eric; Salter, Amber; Frohman, Teresa C; Shah, Anjali; Bates, Angela; Cox, Jennifer L; Dwyer, Michael G; Stüve, Olaf; Greenberg, Benjamin M; Racke, Michael K; Zivadinov, Robert

Frohman, Elliot M; Cutter, Gary; Remington, Gina; Gao, Hongjiang; Rossman, Howard; Weinstock-Guttman, Bianca; Durfee, Jacqueline E; Conger, Amy; Carl, Ellen; Treadaway, Katherine; Lindzen, Eric; Salter, Amber; Frohman, Teresa C; Shah, Anjali; Bates, Angela; Cox, Jennifer L; Dwyer, Michael G; Stüve, Olaf; Greenberg, Benjamin M; Racke, Michael K; Zivadinov, Robert.

Afiliación

Frohman EM; Departments of Neurology and Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Ther Adv Neurol Disord ; 3(1): 15-28, 2010 Jan.

Article en En | MEDLINE | ID: mdl-21180633

Palabras clave

CellCept; MRI activity; immunosuppression; interferon beta 1a; mycophenolate mofetil; relapsing-remitting multiple sclerosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Ther Adv Neurol Disord Año: 2010 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google